Catalyst Pharmaceutical CPRX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $214.33M+30.8% | $163.89M+130% | $71.41M-14.0% | $83.08M+110% | ||
| $375K-5.5% | $397K+25.6% | $316K+124% | $141K-26.6% | ||
| $24.78M+11.4% | $22.25M+56.1% | $14.25M+80.2% | $7.91M+30.2% | ||
| $208.67M-13.0% | $239.81M+67.0% | $143.6M+23.7% | $116.05M+92.2% | ||
| $58K-89.6% | $556K+141% | $231K+697% | $29K-97.2% | ||
| -$58K+89.6% | -$556K+99.8% | -$293.5M-3,287% | $9.21M+184% | ||
| $25.3M— | $0— | —— | —— | ||
| -$16.99M-112% | $146.64M+1,451% | -$10.86M-741% | $1.69M+121% | ||
| $191.62M-49.6% | $379.92M— | —— | $126.95M+208% | ||
| $208.61M-12.8% | $239.25M+66.9% | $143.37M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Catalyst Pharmaceutical generate?
- Catalyst Pharmaceutical (CPRX) generated $208.2M in operating cash flow over the trailing twelve months.
- What is Catalyst Pharmaceutical's free cash flow?
- After $85.0K of capital expenditures, Catalyst Pharmaceutical's free cash flow was $208.1M over the trailing twelve months, down 22.2% year over year.
- Where does Catalyst Pharmaceutical's cash flow data come from?
- Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
